Stockwinners

Stockwinners

Share

In 2019 our return was 32.4% Stockwinners is one of the oldest stock advisory services on the web. We believe that education and up-to-date information are the best tools available to today's investors. We provide upgrades downgrades, latest financial news, earnings report, real time option reports on our site. Everyday via email members receive stock picks including entry price, stop loss, and ta

12/17/2023

Happy Holidays from all of us at Stockwinners

Burford Capital Shares Soar on it’s Court Victory – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research 09/08/2023

https://www.stockwinners.com/blog/2023/09/08/burford-capital-shares-soar-on-its-court-victory/
$BUR $YPF

Burford Capital Shares Soar on it’s Court Victory – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research Posted on September 8, 2023 by Stockwinners ComBurford Capital Shares Soar on it’s Court Victory Argentina ordered to pay at least $8.4B in YPF suit with claims owned by Burford Argentina was ordered to pay at least $8.4B in damages in a U.S. lawsuit over its 2012 re-nationalization of state oil c...

Adenza sold for $10.5 billion – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research 06/12/2023

https://www.stockwinners.com/blog/2023/06/12/adenza-sold-for-10-5-billion/
$NDAQ

Adenza sold for $10.5 billion – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research Posted on June 12, 2023 by Stockwinners ComAdenza sold for $10.5 billion Nasdaq to acquire Adenza from Thoma Bravo for $10.5B in cash and stock Nasdaq (NDAQ) announced it has entered into a definitive agreement to acquire Adenza, a provider of mission-critical risk management and regulatory software...

Eli Lilly Shares Higher on Alzheimer’s Drug! – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research 05/03/2023

https://www.stockwinners.com/blog/2023/05/03/eli-lilly-shares-higher-on-alzheimers-drug/
$LLY $BIIB

Eli Lilly Shares Higher on Alzheimer’s Drug! – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research Posted on May 3, 2023 by Stockwinners ComEli Lilly Shares Higher on Alzheimer’s Drug! Eli Lilly TRAILBLAZER-ALZ 2 met primary endpoint, all secondary endpoint Eli Lilly (LLY) announced results of the TRAILBLAZER-ALZ 2 Phase 3 study showing that donanemab significantly slowed cognitive and function...

Want your business to be the top-listed Finance Company in Austin?
Click here to claim your Sponsored Listing.

Address


Austin, TX
78758